| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Emory University School of Medicine (S.D.B., Y.L., G.A.H., M.R.), Department of Orthopaedic Surgery, and Atlanta Veterans Affairs Medical Center, Decatur, Georgia 30033; Division of Endocrinology and Metabolism (F.L.T., M.S.N.), Emory University School of Medicine, Atlanta Veterans Affairs Medical Center, Decatur, Georgia 30033; and University of California San Francisco School of Medicine (J.A.H., D.H.), Department of Orthopaedic Surgery, San Francisco, California 94143
Address all correspondence and requests for reprints to: Scott D. Boden, M.D., The Emory Spine Center, 2165 North Decatur Road, Decatur, Georgia 30033.
Glucocorticoids can promote osteoblast differentiation from fetal calvarial cells and bone marrow stromal cells. We recently reported that glucocorticoid specifically induced bone morphogenetic protein-6 (BMP-6), a glycoprotein signaling molecule that is a multifunctional regulator of vertebrate development. In the present study, we used fetal rat secondary calvarial cultures to determine genes induced during early osteoblast differentiation as initiated by glucocorticoid treatment.
Glucocorticoid, and subsequently BMP-6, was found to induce a novel rat intracellular protein, LIM mineralization protein-1 (LMP-1), that in turn resulted in synthesis of one or more soluble factors that could induce de novo bone formation. Blocking expression of LMP-1 using antisense oligonucleotide prevented osteoblast differentiation in vitro. Overexpression of LMP-1 using a mammalian expression vector was sufficient to initiate de novo bone nodule formation in vitro and in sc implants in vivo. These data demonstrate that LMP-1 is an essential positive regulator of the osteoblast differentiation program as well as an important intermediate step in the BMP-6 signaling pathway.
This article has been cited by other articles:
![]() |
T. Camarata, B. Bimber, A. Kulisz, T.-L. Chew, J. Yeung, and H.-G. Simon LMP4 regulates Tbx5 protein subcellular localization and activity J. Cell Biol., July 31, 2006; 174(3): 339 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sangadala, S. D. Boden, M. Viggeswarapu, Y. Liu, and L. Titus LIM Mineralization Protein-1 Potentiates Bone Morphogenetic Protein Responsiveness via a Novel Interaction with Smurf1 Resulting in Decreased Ubiquitination of Smads J. Biol. Chem., June 23, 2006; 281(25): 17212 - 17219. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Loughran, N. C. Healy, P. A. Kiely, M. Huigsloot, N. L. Kedersha, and R. O'Connor Mystique Is a New Insulin-like Growth Factor-I-regulated PDZ-LIM Domain Protein That Promotes Cell Attachment and Migration and Suppresses Anchorage-independent Growth Mol. Biol. Cell, April 1, 2005; 16(4): 1811 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Minamide, S. D. Boden, M. Viggeswarapu, G. A. Hair, C. Oliver, and L. Titus Mechanism of Bone Formation with Gene Transfer of the cDNA Encoding for the Intracellular Protein LMP-1 J. Bone Joint Surg. Am., May 28, 2003; 85(6): 1030 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hannallah, B. Peterson, J. R. Lieberman, F. H. Fu, and J. Huard Gene Therapy in Orthopaedic Surgery J. Bone Joint Surg. Am., June 1, 2002; 84(6): 1046 - 1061. [Full Text] |
||||
![]() |
Y. G. Amaar, G. R. Thompson, T. A. Linkhart, S.-T. Chen, D. J. Baylink, and S. Mohan Insulin-like Growth Factor-binding Protein 5 (IGFBP-5) Interacts with a Four and a Half LIM Protein 2 (FHL2) J. Biol. Chem., March 29, 2002; 277(14): 12053 - 12060. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Viggeswarapu, S. D. Boden, Y. Liu, G. A. Hair, J. Louis-Ugbo, H. Murakami, H. S. Kim, M. T. Mayr, W. C. Hutton, and L. Titus Adenoviral Delivery of LIM Mineralization Protein-1 Induces New-Bone Formation in Vitro and in Vivo J. Bone Joint Surg. Am., March 1, 2001; 83(3): 364 - 364. [Abstract] [Full Text] |
||||
![]() |
L. Gilbert, X. He, P. Farmer, S. Boden, M. Kozlowski, J. Rubin, and M. S. Nanes Inhibition of Osteoblast Differentiation by Tumor Necrosis Factor-{alpha} Endocrinology, November 1, 2000; 141(11): 3956 - 3964. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vallenius, K. Luukko, and T. P. Makela CLP-36 PDZ-LIM Protein Associates with Nonmuscle alpha -Actinin-1 and alpha -Actinin-4 J. Biol. Chem., April 6, 2000; 275(15): 11100 - 11105. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |